# Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1

> **NCT03570450** · PHASE1 · RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 95 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Adipose derived Stem Cell
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03570450
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-02
- **Primary completion:** 2025-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570450, "Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03570450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*